Corporate Sponsorships
Gilead Sciences' Corporate Sponsorships fund nonprofit events advancing research and education in HIV, liver disease, oncology, and chronic inflammatory diseases.
Funder: Gilead Sciences
Due Dates: Rolling (apply at least 6 weeks before event; 3–6 months lead time recommended)
Funding Amounts: No set minimum or maximum; funding commensurate with event scope and sponsorship tier; typically for single events (not multi-year/ongoing programs).
Summary: Supports nonprofit-led events and conferences addressing health disparities in HIV, liver disease, oncology, and chronic inflammatory diseases.
Key Information: Only organizations (not individuals) may apply; must align with Gilead focus areas and provide detailed event budget.
Description
Gilead Sciences' Corporate Sponsorships program provides financial support for events and conferences that raise awareness and advance efforts in the company's core therapeutic areas: HIV, liver diseases (including hepatitis B, C, D, and primary biliary cholangitis), oncology (hematology and solid tumors), and chronic inflammatory diseases. The program is designed to amplify initiatives that promote education, reduce health disparities, and improve access to care for underserved and marginalized populations. Sponsorships are intended for single, time-limited events or conferences—not for general operating support or ongoing programs.
